A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
Zeyan Xu,Yong Li,Yingyi Wang,Shenyan Zhang,Yanqi Huang,Su Yao,Chu Han,Xipeng Pan,Zhenwei Shi,Yun Mao,Yao Xu,Xiaomei Huang,Huan Lin,Xin Chen,Changhong Liang,Zhenhui Li,Ke Zhao,Qingling Zhang,Zaiyi Liu
DOI: https://doi.org/10.1186/s12935-021-02297-w
IF: 6.429
2021-10-30
Cancer Cell International
Abstract:Abstract Background Profound heterogeneity in prognosis has been observed in colorectal cancer (CRC) patients with intermediate levels of disease (stage II–III), advocating the identification of valuable biomarkers that could improve the prognostic stratification. This study aims to develop a deep learning-based pipeline for fully automatic quantification of immune infiltration within the stroma region on immunohistochemical (IHC) whole-slide images (WSIs) and further analyze its prognostic value in CRC. Methods Patients from two independent cohorts were divided into three groups: the development group (N = 200), the internal (N = 134), and the external validation group (N = 90). We trained a convolutional neural network for tissue classification of CD3 and CD8 stained WSIs. A scoring system, named stroma-immune score, was established by quantifying the density of CD3 + and CD8 + T-cells infiltration in the stroma region. Results Patients with higher stroma-immune scores had much longer survival. In the development group, 5-year survival rates of the low and high scores were 55.7% and 80.8% (hazard ratio [HR] for high vs. low 0.39, 95% confidence interval [CI] 0.24–0.63, P < 0.001). These results were confirmed in the internal and external validation groups with 5-year survival rates of low and high scores were 57.1% and 78.8%, 63.9% and 88.9%, respectively (internal: HR for high vs. low 0.49, 95% CI 0.28–0.88, P = 0.017; external: HR for high vs. low 0.35, 95% CI 0.15–0.83, P = 0.018). The combination of stroma-immune score and tumor-node-metastasis (TNM) stage showed better discrimination ability for survival prediction than using the TNM stage alone. Conclusions We proposed a stroma-immune score via a deep learning-based pipeline to quantify CD3 + and CD8 + T-cells densities within the stroma region on WSIs of CRC and further predict survival.
oncology